MarketsandMarkets Partners With IIR USA for Their Event 'Advanced Biomarker Strategies in Oncology Drug Development'

DALLAS, February 1 - The organizers of the Annual Partnerships in Clinical Trials
and Central Labs events present Advanced Biomarker Strategies in Oncology
Drug Development. The conference is organized at the Grand Hyatt, San
Francisco from February 4-5, 2010. This event is FREE for executives from the
biotech and pharmaceutical industries.

This two-day program focuses exclusively on the latest
developments in oncology biomarkers. It provides an opportunity to interact
with the leaders in clinical R&D, oncology, drug development, and
translational research. The program aims to deliver and develop solutions,
industry standards, and practical applications for biomarker development and
validation. This unique program is the first of our three part Target
Clinical Trials Series, delivering therapeutic-specific strategies to
facilitate execution of successful clinical trials.

For more information on this event, please visit
www.iirusa.com/targetbiomarkers.

For more information on the Target Clinical Trial Series, visit
www.clinicaltrialseries.com.

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that
publishes 120 market research reports per year. Each strategically analyzed
report contains 250 pages of valuable market data, including more than 100
market data summary tables and in-depth, five-level segmentation for each of
the products, services, applications, technologies, ingredients and
stakeholders categories. Our reports also analyze about 200 patents, over 50
companies and micro markets that are mutually exclusive and collectively
exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.

The Global Biomarker Market report published by
MarketsandMarkets analyzes the global biomarker tools and services markets
over the period 2009-2014. The report studies the major market drivers,
restraints, and opportunities for the global biomarker market; and evaluates
the major trends in the macro- and micro-markets with respect to different
geographic regions.

The global biomarker market is estimated to be $20.5 billion
by 2014, growing at a CAGR of 19.7 % from 2009 to 2014. Market growth is
driven mainly by the high demand for biomarkers in the field of drug
discovery; from the increasing demand from the baby boomer generation in the
U.S.; and from Asia's emerging IT industry. Biomarker applications are
increasing in cancer diagnosis as novel tools are being developed to increase
the discovery speed of cancer biomarkers.

SCOPE AND FORMAT

The report analyzes the global biomarker market into the following
segments:

    - Tools Market-(pregenomic biomarkers and technologies, post
      genomic biomarkers and technologies, imaging biomarkers, and others)

    - Services Market-(pre- and post-clinical biomarker services,
      sample preparation, mirna analysis, and others)

    - Application Market-(diagnosis, and drug development and discovery)

    Contact
    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com

Contact: Ms. Sunita, 7557 Rambler Road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004, Email: sales at marketsandmarkets.com